文献速递眼底病与葡萄膜炎

44通道脉络膜上视网膜假体的安全性研究:一项慢性被动研究

Safety Studies for a 44-Channel Suprachoroidal Retinal Prosthesis: A Chronic Passive Study.
PubMed 文献 · Invest Ophthalmol Vis Sci · 2018-01-01

本研究在10只正常视力猫单侧眼植入44通道脉络膜上视网膜假体,评估其被动安全性,随访至20周。8只动物电极阵列插入安全且与视网膜曲度贴合良好,8只机械稳定仅轻微(<2个视盘直径)横向移动,发生4例手术或稳定性并发症;视网膜结构和功能无变化,组织病理显示轻度异物反应。作者认为该阵列具有可接受的被动安全性,可进入临床试验。

要点

  • 10只猫单侧眼植入44通道脉络膜上电极阵列,随访至20周。
  • 8只动物插入安全、贴合良好,8只机械稳定仅轻微(<2个视盘直径)横向移动。
  • 发生4例并发症:术中脉络膜膨隆、全身出血性疾病所致出血、感染、薄后巩膜部分侵蚀。

核心结论

  • 作者认为44通道脉络膜上电极阵列具有可接受的被动安全性,可进入临床试验。
  • 作者认为安全性预期在人体研究中会改善,因为所见并发症是猫模型解剖差异限制所特有。

研究设计与样本

  • 10只正常视力猫单侧眼植入含铂电极(44个刺激电极和2个回路电极)的硅胶载体阵列,置于中央区附近。
  • 在麻醉下于术前及术后纵向至20周进行临床评估(彩色眼底照相、光学相干断层扫描、全视野视网膜电图、眼压)。
  • 对2只动物在13至15周进行纤维化和炎症的组织病理学分级。

主要发现

  • 8只动物电极阵列插入安全(视网膜健康良好),阵列与视网膜曲度贴合良好。
  • 8只动物阵列机械稳定良好,仅轻微(<2个视盘直径)横向移动。
  • 发生4例手术或稳定性并发症:术中脉络膜膨隆、全身出血性疾病所致出血、感染、薄后巩膜部分侵蚀。
  • 终点时视网膜结构或功能无变化(除术中已见者外)。
  • 组织病理学显示轻度异物反应,移除电极阵列时电极完整。

局限性

  • 作者认为所见并发症是猫模型解剖差异限制所特有,安全性预期在人体研究中会改善。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Following successful clinical outcomes of the prototype suprachoroidal retinal prosthesis, Bionic Vision Australia has developed an upgraded 44-channel suprachoroidal retinal prosthesis to provide a wider field of view and more phosphenes. The aim was to evaluate the preclinical passive safety characteristics of the upgraded electrode array. METHODS: Ten normal-sighted felines were unilaterally implanted with an array containing platinum electrodes (44 stimulating and 2 returns) on a silicone carrier near the area centralis. Clinical assessments (color fundus photos, optical coherence tomography, full-field electroretinography, intraocular pressure) were performed under anesthesia prior to surgery, and longitudinally for up to 20 weeks. Histopathology grading of fibrosis and inflammation was performed in two animals at 13 to 15 weeks. RESULTS: Eight animals showed safe electrode array insertion (good retinal health) and good conformability of the array to the retinal curvature. Eight animals demonstrated good mechanical stability of the array with only minor (<2 disc diameters) lateral movement. Four cases of surgical or stability complications occurred due to (1) bulged choroid during surgery, (2) hemorrhage from a systemic bleeding disorder, (3) infection, and (4) partial erosion of thin posterior sclera. There was no change in retinal structure or function (other than that seen at surgery) at endpoint. Histopathology showed a mild foreign body response. Electrodes were intact on electrode array removal. CONCLUSIONS: The 44-channel suprachoroidal electrode array has an acceptable passive safety profile to proceed to clinical trial. The safety profile is expected to improve in human studies, as the complications seen are specific to limitations (anatomic differences) with the feline model.

来源:Invest Ophthalmol Vis Sci,查看原文。版权归原作者所有。

引用

  1. Abbott CJ, Nayagam DAX, Luu CD, et al. Safety Studies for a 44-Channel Suprachoroidal Retinal Prosthesis: A Chronic Passive Study. Invest Ophthalmol Vis Sci. 2018. PMID: 29625464. doi:10.1167/iovs.17-23086

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。